
Sign up to save your podcasts
Or


Mike Perrone, CFA, Managing Director at Baird, discusses the forces reshaping healthcare investing in 2026 and their impact on portfolio construction. He also shares his views on the biotech sector, evolution of GLP-1 drugs, role of artificial intelligence and outlook for M&A.
By CFA Society New York4.6
99 ratings
Mike Perrone, CFA, Managing Director at Baird, discusses the forces reshaping healthcare investing in 2026 and their impact on portfolio construction. He also shares his views on the biotech sector, evolution of GLP-1 drugs, role of artificial intelligence and outlook for M&A.

3,347 Listeners

2,175 Listeners

1,993 Listeners

943 Listeners

2,020 Listeners

2,145 Listeners

556 Listeners

84 Listeners

150 Listeners

403 Listeners